Related Experiment Video
Updated: Feb 2, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
BLASSO: integration of biological knowledge into a regularized linear model
Daniel Urda1, Francisco Aragón2, Rocío Bautista3
1Universidad de Cádiz, Departamento de Ingeniería Informática, Avda. de la Universidad de Cádiz n°10, Puerto Real, Cádiz, 11519, Spain. daniel.urda@uca.es.
BLASSO, a new model integrating biological knowledge, improves breast cancer outcome prediction and biomarker stability over standard LASSO. It identifies novel cancer-related genes, enhancing RNA-Seq analysis for complex traits.
Area of Science:
- Computational biology and bioinformatics
- Genomics and transcriptomics
- Biomedical data analysis
Background:
- Identifying genetic signatures for complex human traits from RNA-Seq data is challenging due to high gene correlation and instability in biomarker selection.
- Existing methods often yield low overlap rates for genetic signatures across different studies.
- Predictive models for complex traits require robust and stable biomarker identification.
Purpose of the Study:
- To propose BLASSO, a linear model with L1-regularization, incorporating prior biological knowledge for predicting breast cancer outcomes.
- To evaluate two distinct approaches (Gene-specific and Gene-disease) for integrating biological knowledge within BLASSO.
- To assess the predictive performance and biomarker stability of BLASSO compared to a baseline LASSO model using RNA-Seq data.
Main Methods:
- Development of BLASSO, a linear model with L1-regularization, enhanced with two strategies for biological knowledge integration.
- Utilized a public RNA-Seq gene expression dataset for breast cancer.
- Employed 10-fold cross-validation with 100 repetitions for model assessment and calculated the robustness index (RI) for biomarker stability.
Main Results:
- BLASSO achieved higher average AUC values (0.7 for Gene-specific, 0.69 for Gene-disease) compared to LASSO (0.65).
- BLASSO demonstrated superior biomarker stability, with the Gene-specific approach showing a 66% increase in robustness (RI of 0.15±0.03 vs. 0.09±0.03 for LASSO).
- Functional analysis of BLASSO-derived signatures revealed known cancer-related genes and identified novel candidates like IFNK and PCNAP1.
Conclusions:
- BLASSO is an effective choice for breast cancer outcome prediction, offering improved efficacy and biomarker stability over traditional methods.
- The integration of biological knowledge into BLASSO enhances the interpretability and robustness of identified genetic signatures.
- BLASSO facilitates the discovery of both established and potentially novel genes involved in cancer pathogenesis.
Related Concept Videos
Growth Models with Integration: Problem Solving
Linear Circuits
Linear Equations
Linear Momentum
Linearization and Approximation
What is Conservation Biology?

